Daniel Rogers Hair Advantage Growth Claims Stunted By NAD
This article was originally published in The Rose Sheet
Executive Summary
Daniel Rogers' claims that its Hair Advantage hair growth product contains FDA-approved minoxidil to stimulate new hair growth and reverse hair loss should be modified to more accurately represent the ingredient's efficacy or be discontinued altogether, the National Advertising Division of the Council for Better Business Bureaus recommends following a recent inquiry
You may also be interested in...
Nioxin “Excessive Daily Hair Loss” Claim Should Be Discontinued – NAD
Nioxin Research Labs ad and packaging claims stating its hair care products "help reduce excessive daily hair loss" should be discontinued because they imply a "performance benefit" beyond simple shampooing, yet are not supported by scientific evidence, the National Advertising Division of the Council of Better Business Bureaus states in an upcoming Case Reports
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle